Lit Matters #3: 2025 ATS CAP Guidelines Update

Community-acquired pneumonia now reflects host susceptibility, lung microbiome dysbiosis, and alveolar inflammation rather than simple invasion of a sterile lung. The 2025 ATS update shifts CAP care toward ultrasound-supported diagnosis, selective antibiotics after a positive viral PCR, shorter courses once patients are clinically stable, and steroids only in the right inpatient phenotype.

2025 CAP Guideline Practice Shifts

• Lung ultrasound diagnosis: Lung ultrasound is an acceptable alternative to chest radiography for suspected CAP when operator expertise exists, and it may help when chest x-ray is negative but suspicion remains high.
• Positive viral PCR context: A positive respiratory viral panel does not reliably exclude bacterial coinfection, so empiric antibiotics are generally withheld only in otherwise healthy outpatients without comorbidities.
• Clinical stability shortening: Antibiotic duration can be shorter than 5 days for stable outpatients and selected non-severe inpatients, but severe CAP still generally needs at least 5 days. We get into the stability criteria in the episode.
• Severe CAP steroids: Systemic corticosteroids are not recommended for non-severe inpatient CAP, but severe CAP is different, with an estimated 1 death prevented for every 17 treated patients.
• Influenza caution: Severe influenza pneumonia remains an important exception because observational data suggest corticosteroid harm, even as steroids may help in other severe CAP phenotypes.

CAP Pathophysiology And Bedside Judgment

• Modern CAP model: CAP is better framed as dysbiosis, inflammation, and tissue injury in a susceptible host, which helps explain why microbiology, imaging, and treatment decisions rarely fit a single rule.
• Imaging confirms disease: CAP diagnosis still requires compatible symptoms plus chest imaging showing alveolar inflammation; clinical impression alone is not enough to establish the diagnosis.
• Coinfection uncertainty: No clinical, radiographic, or laboratory test can reliably separate viral pneumonia from bacterial coinfection, which is why viral PCR results must be interpreted in context.
• Long course harms: Prolonged antibiotic therapy carries real downside, including C difficile, acute kidney injury, adverse drug effects, and microbiome disruption, without clear benefit in stable patients.
• Exceptions to shortcuts: Short courses and simplified pathways do not apply cleanly to necrotizing infection, abscess, empyema, resistant organisms, or major chronic lung disease. We cover the important caveats on the show.

Patient Communication In CAP

• Recommendation rationale: Good CAP communication starts with why a test or treatment is being recommended, using plain language that links the plan to the patient's illness and priorities.
• Certainty and tradeoffs: Patients should hear how strong the recommendation is and the main tradeoffs, including side effects, cost, convenience, and the risk of undertreating or overtreating infection.
• Expected clinical course: Set expectations for recovery, follow-up, and return precautions early, because realistic timelines and warning signs are part of safe outpatient and inpatient CAP care.
• Shared follow-up planning: Clear instructions on how to contact the team and arrange follow-up are part of the treatment plan, especially when antibiotics are withheld or shortened.